Literature DB >> 29375127

Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.

Weici Zhang1, Ren Zhang2,3, Jun Zhang2, Ying Sun2,4, Patrick Sc Leung2, Guo-Xiang Yang2, Zongwen Shuai2,5, William M Ridgway6, M Eric Gershwin7.   

Abstract

Autoimmune cholangitis arises from abnormal innate and adaptive immune responses in the liver, and T cells are critical drivers in this process. However, little is known about the regulation of their functional behavior during disease development. We previously reported that mice with T cell-restricted expression of a dominant negative form of transforming growth factor beta receptor type II (dnTGFβRII) spontaneously develop an autoimmune cholangitis that resembles human primary biliary cholangitis (PBC). Adoptive transfer of CD8+ but not CD4+ T cells into Rag1-/- mice reproduced the disease, demonstrating a critical role for CD8+ T cells in PBC pathogenesis. Herein, we used SOMAscan technology to perform proteomic analysis of serum samples from dnTGFβRII and B6 control mice at different ages. In addition, we analyzed CD8 protein profiles after adoptive transfer of splenic CD8+ cells into Rag1-/- recipients. The use of the unique SOMAscan aptamer technology revealed critical and distinct profiles of CD8 cells, which are key to biliary mediation. In total, 254 proteins were significantly increased while 216 proteins were significantly decreased in recipient hepatic CD8+ cells compared to donor splenic CD8+ cells. In contrast to donor splenic CD8+ cells, recipient hepatic CD8+ cells expressed distinct profiles for proteins involved in chemokine signaling, focal adhesion, T cell receptor and natural killer cell-mediated cytotoxicity pathways.

Entities:  

Keywords:  CD8; autoimmune cholangitis; dnTGFβRII mice; proteomic analysis

Mesh:

Substances:

Year:  2018        PMID: 29375127      PMCID: PMC6141482          DOI: 10.1038/cmi.2017.149

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  58 in total

1.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  TGF-β decreases the stability of IL-18-induced IFN-γ mRNA through the expression of TGF-β-induced tristetraprolin in KG-1 cells.

Authors:  Yasumichi Inoue; Kenji Abe; Kikuo Onozaki; Hidetoshi Hayashi
Journal:  Biol Pharm Bull       Date:  2015       Impact factor: 2.233

3.  Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis.

Authors:  Ya-Hui Chuang; Zhe-Xiong Lian; Koichi Tsuneyama; Bor-Luen Chiang; Aftab A Ansari; Ross L Coppel; M Eric Gershwin
Journal:  J Autoimmun       Date:  2006-05-26       Impact factor: 7.094

4.  Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis.

Authors:  H Tanaka; G-X Yang; T Tomiyama; K Tsuneyama; W Zhang; P S C Leung; R L Coppel; T Joh; S G Nadler; A A Ansari; C Bowlus; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

Review 5.  Immunity, tolerance and autoimmunity in the liver: A comprehensive review.

Authors:  Derek G Doherty
Journal:  J Autoimmun       Date:  2015-09-07       Impact factor: 7.094

6.  Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.

Authors:  L Gorelik; R A Flavell
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

7.  Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.

Authors:  Aki Ikeda; Nobuhiro Aoki; Masahiro Kido; Satoru Iwamoto; Hisayo Nishiura; Ryutaro Maruoka; Tsutomu Chiba; Norihiko Watanabe
Journal:  Hepatology       Date:  2014-05-28       Impact factor: 17.425

8.  Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis.

Authors:  George F Mells; James A B Floyd; Katherine I Morley; Heather J Cordell; Christopher S Franklin; So-Youn Shin; Michael A Heneghan; James M Neuberger; Peter T Donaldson; Darren B Day; Samantha J Ducker; Agnes W Muriithi; Elizabeth F Wheater; Christopher J Hammond; Muhammad F Dawwas; David E Jones; Leena Peltonen; Graeme J Alexander; Richard N Sandford; Carl A Anderson
Journal:  Nat Genet       Date:  2011-03-13       Impact factor: 38.330

9.  FoxQ1 promotes glioma cells proliferation and migration by regulating NRXN3 expression.

Authors:  Hong-Tao Sun; Shi-Xiang Cheng; Yue Tu; Xiao-Hong Li; Sai Zhang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Liver autoimmunity triggered by microbial activation of natural killer T cells.

Authors:  Jochen Mattner; Paul B Savage; Patrick Leung; Sabine S Oertelt; Vivien Wang; Omita Trivedi; Seth T Scanlon; Krishna Pendem; Luc Teyton; John Hart; William M Ridgway; Linda S Wicker; M Eric Gershwin; Albert Bendelac
Journal:  Cell Host Microbe       Date:  2008-05-15       Impact factor: 21.023

View more
  3 in total

Review 1.  Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Lindsey Kennedy; Suthat Liangpunsakul; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2019-04-22       Impact factor: 6.902

2.  Aptamer based proteomic pilot study reveals a urine signature indicative of pediatric urinary tract infections.

Authors:  Liang Dong; Joshua Watson; Sha Cao; Samuel Arregui; Vijay Saxena; John Ketz; Abduselam K Awol; Daniel M Cohen; Jeffrey M Caterino; David S Hains; Andrew L Schwaderer
Journal:  PLoS One       Date:  2020-07-06       Impact factor: 3.240

3.  Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice.

Authors:  Michael Ziemba; Molly Barkhouse; Kitipong Uaesoontrachoon; Mamta Giri; Yetrib Hathout; Utkarsh J Dang; Heather Gordish-Dressman; Kanneboyina Nagaraju; Eric P Hoffman
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.